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ABSTRACT 
Introduction: Brucellosis is a zoonotic disease contributing to 
significant health and economic problems worldwide. The aim of  
this study was to investigate the seroprevalence and the associated 
risk factors of  brucellosis among people admitted to Azadi general 
hospital, Duhok, Iraq. Patients and Methods: A total of  1283 
patient blood samples (603 males and 680 females) were collected 
through the period of  January 2017 to December 2017 from people 
at different age groups admitting Azadi general hospital, Duhok, 
Iraq. All collected sera were screened for the seroprevalence of  
Brucella using Rose Bengal plate test kit. Results: Among the 1283 
blood samples, the overall seroprevalence of  brucellosis was 17.8%. 
The highest rate was recorded in age group between 21–30 years 
(22.7%) and the different distribution of  human brucellosis among 
age groups was statistically significant (p=0.0076). The frequency 
of  brucellosis in females (20%) was significantly higher than males 
(15.3%) (p=026). The distribution of  brucellosis according to the 
seasonal changes was statistically significant (p= 0.003) (25.64% in 
July and 9.75% in December). Conclusions: The incidence of  the 
brucellosis is high, and it remains a challenging health problem. The 
age, gender, and seasonal changes are considered as important risk 
factors for the distribution of  the diseases. Surveillance programs 
and active screening for brucellosis are essential to prevent, control, 
and to reduce the incidence of  the brucellosis.
La seroprevalencia de la brucelosis humana en pacientes de diferentes 
grupos de edad y otros factores de riesgo asociados en Duhok, Iraq
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2INTRODUCCTION 
Brucellosis is a systemic infectious disease transmit-
ted from certain animals to human (1). This zoonotic 
disease is endemic in Iraq and worldwide (2). It has 
various terms such as Malta fever, undulant fever 
and Mediterranean fever (3). More than 0.5 million 
human brucellosis cases are reported annually and 
in some countries, the incidence rate is more than 
10 cases per 100,000 population (4, 5). The most 
pathogenic and invasive species of  Brucella that in-
fect human are B. melitensis, followed by B. suis, B. 
abortus and B. canis (3, 6). Human acquires brucellosis 
through direct contact with infected animals or their 
products (7). Brucellosis in human is manifested by 
a various range of  clinical symptoms and signs and 
the undulant fever is the most important symptom 
(3). The symptoms of  the brucellosis in the positive 
serological tests results include sweating, weakness, 
and myalgia (4). Other initial symptoms may include 
headache, fatigue, weight loss, anorexia, muscle and 
joints pain. Furthermore, asymptomatic infections 
can also occur in humans (1). This zoonotic disease 
is considered serious and sometimes chronic disease 
that contributing to significant health and economic 
problems (3). Although brucellosis has been success-
fully eradicated in many countries, it is still endemic 
in many parts of  the world (8, 9) such as the coun-
tries of  Eastern Mediterranean Region, Middle East, 
Africa, Mediterranean basin, central Asia, and Latin 
America. Most parts of  Iraq are still endemic for the 
disease in animals as well as humans (10). Therefore, 
identifying the risk factors of  brucellosis is very im-
portant to understand the nature of  the disease and 
its transmission routes for the eradication of  human 
brucellosis. Thus, the aims of  this study were to as-
sess the present status of  seroprevalence of  brucel-
losis among patient populations in Duhok, Iraq, and 
to investigate the significant effects of  some factors 
such as sex, age, and seasonal variation on the distri-
bution of  brucellosis cases.
PATIENTS AND METHODS 
Sample collection
A total of  1283 blood samples were collected from 
patients at different age groups who attended Aza-
di general hospital, Duhok, Kurdistan region, Iraq 
through the period from January 2017 to December 
2017. All patients with clinical suspicion of  brucello-
sis, who would normally present for laboratory-based 
brucellosis testing, were included in this study. Of  
these, 603 (47%) were male patients and 680 (53%) 
were females. About 5 ml of  blood sample was col-
lected in a sterile vacutainer from each patient. Then, 
the blood samples were centrifuged at 2000 rpm for 
five minutes to obtain the serums. The serum sample 
of  each patient was transferred into 1ml microtubes 
and aliquots were prepared (to prevent the repeated 
freezing-thawing process) and stored at -20°C until 
performing the serological test.
Rose Bengal test
All collected sera were screened for the presence of  
antibodies against Brucella using the commercially 
available Rose Bengal plate test kit (Institute-Pour-
quie/France) as recommended by the manufacturer. 
Briefly, 30µL of  plain serum were dispensed on a 
white glossy ceramic tile and mixed with an equal 
volume of  the Rose Bengal test antigen. The serum 
and the antigen were mixed thoroughly and rapidly 
at room temperature for 4 minutes and any visible 
agglutination was taken as a positive result. Other-
wise, the result was considered as negative (11, 12).
Data analysis
All statistical analysis was performed using the SPSS 
20 software. Chi-squared test was used to assess the 
associations between variables. P value of  <0.05 was 
considered as significant.
3RESULTS 
Seroprevalence of  brucellosis in human 
The results revealed that anti-brucella antibodies 
were detected in 228 out of  1283 blood samples rep-
resenting the overall 17.8% of  the seroprevalence of  
brucellosis (Table 1).
Age distribution of  brucellosis
The seropositivity of  brucellosis was varied in dif-
ferent age groups (Table 1). The highest rate (22.7%) 
was recorded in age group between 21–30 years. The 
elderly patients (older than 50 years) showed less 
prevalence of  brucellosis (11.5%). The different dis-
tribution of  human brucellosis among these two age 
groups was statistically significant (p=0.0076).
Table 1. Age distribution of  brucellosis
 
Age group (Years)  No. of  samples  No.  of Positive (%)  
≤ 10  
11 –  20  
21 –  30  
31 –  40  
41 –  50  
 > 51  
Total  
169  
234  
273  
283  
194  
130  
1283  
21 (12.4)  
41 (17.5)  
62 (22.7)  
59 (20.8)  
30 (15.5)  
15 (11.5)  
228 (17.8)  
Gender difference of  brucellosis
In the present study, there was a significant difference (p=026) of  the frequency of  brucellosis in females pa-
tients (136; 20%) than males (92; 15.3%) (Table 2). In males, the highest percentage of  infected patients was 
at age group 21-30 years (27; 21.4%) and the lowest (7; 8.97%) was at age ≤10 years. There was a significant 
difference found between these two age groups (p=0.020). In females, the age group 21-30 years showed 
highest infection rate (35; 23.81%) and the lowest infection rate was at age group >51 years (8;14.04%). But 
the differences between these two age groups were statistically not significant (p=0.124). 
Table 2. Sex distribution of  brucellosis
 Age group (Years)  Male  Female  
 No. of samples
 
No. of positive (%)  No. of positive (%)  
≤10  78  7 (8.97)  91   
11 -20  94  12 (12.8)  140   
21 -30  126  27 (21.4)  147   
31 -40  134  25 (18.7)  149   
41 -50  98  14 (14.3)  96   
>51  73  7 (9.59)  57   
Total  603  92 (15.3)  680  
14 (15.38)
29 (20.71)
35 (23.81)
34 (22.82)
16 (16.67)
8 (14.04)
136 (20)  
No. of samples
4Seasonal distribution of  brucellosis
Seasonal variations have marked epidemiological interest in brucellosis. In this study, the rate of  brucellosis 
ranged from 9.75% in December to 25.64% in July (p= 0.0086) (Table 3). The distribution of  brucellosis 
according to the seasonal changes was statistically significant (p= 0.003).
Table 3. Seasonal distribution of  brucellosis
Months  No. of samples  No. of positive (%)
January  95  18 (18.95)  
February  94  12 (12.77)  
March  81  10 (12.35)  
April  112  16 (14.29)  
May  99  16 (16.16)  
June  169  42 (24.85)  
July  156  40 (25.64)  
August  124  28 (22.58)  
September  101  16 (15.84)  
October  91  14 (15.38)  
November  79  8 (10.13)  
December  82  8 (9.756)  
Total  1283  228 (17.77)  
DISCUSSION 
Brucellosis is a zoonotic disease that is transmitta-
ble from animals to human. Although brucellosis 
has been controlled in most developed countries, it 
remains an important public health problem in de-
veloping countries. The Rose Bengal test (RBT) is 
a rapid screening test and although it was designed 
originally for screening use in veterinary medicine, 
but is now often used for the diagnosis of  human 
brucellosis (13, 14). The sensitivity of  the Rose Ben-
gal plate test is more than 99%, and the rate of  
false-negative results is infrequent (15). The RBT is 
the most common serological test used in Iraq for 
detection of  human brucellosis.
The seroprevalence of  brucellosis in the current 
study was 17.8%. The human brucellosis rates were 
varied in different studies in Iraqi provinces (2, 16). The 
current rate was high compared to previous studies 
in the region. In 2015, the prevalence rate was 9.5% 
in Erbil and 13.2% in Mosul (2). However, other 
studies showed higher rates in the country. In 2015, 
high rates of  a positive result by RBT were report-
ed among people in Al-Sulaymaniyah and Baghdad 
regions (59.82% and 71.3% respectively) (2, 16). Our 
records were higher than records from neighboring 
countries. For example, the prevalence of  brucellosis 
in Turkey and Saudi was 6% and 12.5% respective-
ly (5, 17). Human brucellosis is still endemic in many 
parts of  the world, such as Africa, Middle East, Lat-
in America and Asia (18-20). The main risk factors for 
5brucellosis are the direct contact with infected ani-
mals and consumption of  unpasteurized dairy prod-
ucts especially those which are locally made (21). Ad-
ditionally, many factors can play a significant role in 
the variation of  the incidence of  brucellosis, such as 
the demographic, occupational, and socioeconom-
ic factors (22). Also, occupational exposure is seen in 
laboratory workers, veterinarians, farmers, and oth-
ers who contact infected animals or tissues.
The age is one of  the important risk factors for dis-
tribution the brucellosis worldwide. In the current 
study, the highest rate of  brucellosis (22.7%) was 
observed in the age group 21-30 years. Comparable 
findings were reported from different studies locally 
and worldwide (3, 23-25). This would be expected be-
cause the brucellosis is an occupational disease and 
this age group exposed longer to risk factors relat-
ed to their occupation. Data revealed that people in 
certain occupation can get infected with brucellosis 
more than others (26).   
The prevalence of  brucellosis among females was 
significantly higher than males. This finding was in 
agreement with other studies in the region. Although 
some studies showed that more males were affect-
ed than females (26, 27), other studies revealed that the 
infection of  brucellosis is predominant among fe-
males than males (2, 25, 28). It is obvious in our region 
that females are more likely involved in household 
than males. Women are more concerned in domestic 
livestock and cows and other activities and as a con-
sequence women may in greater risk to acquire the 
infection.
There were seasonal fluctuations in the incidence of  
brucellosis. The current study showed that the larg-
est number of  brucellosis cases were occurring in 
summer (July) while the lowest incidence occurred 
during winter (December). Similar seasonal pattern 
have been shown in several studies achieved local-
ly and in neighboring countries (2, 4, 26). This seasonal 
pattern of  brucellosis could be due to different fac-
tors for example summer season is the delivery (par-
turition) season of  sheep and goats which increase 
the chance for direct contact with infected animals, 
their secretions could lead to infection through in-
halation or accidental skin and mucous membrane 
penetration. Also, in summer season more opportu-
nities for consumption of  contaminated dairy prod-
ucts such as raw milk or fresh cheese which increase 
the chance of  infection (5, 29). 
CONCLUSION 
Brucellosis is one of  the important bacterial zoo-
notic diseases contributing to significant health and 
economic problems. It is a serious and debilitating 
disease that affects a variety of  organs. Brucellosis is 
endemic in Duhok, Iraq. The incidence of  the bru-
cellosis is high and it remains a challenging health 
problem. Iraq has not been able to eradicate the dis-
ease and the population is still at great risk of  acquir-
ing it. The age, gender, seasonal changes are consid-
ered as important risk factors for the distribution of  
human brucellosis. Identifying the major risk factors 
for brucellosis will help to understand the nature 
of  the disease and its transmission routes for erad-
ication of  human brucellosis. Furthermore, surveil-
lance programs are essential to prevent and control 
brucellosis effectively. Also, the active screening for 
brucellosis will lead to early identification and conse-
quently early initiation of  therapy that will reduce the 
incidence of  the brucellosis.
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